Moreover, transgenic mice that express AD-related mutations exhibited accelerated rates of Aβ deposition concomitant with hemizygous deletion of the TTR gene (Choi et al., 2007) whereas overexpression of TTR suppressed pathological and behavioral abnormalities associated with a transgenic model of AD (Buxbaum et al., 2008). Here, TTR is linked to Alzheimer disease.